Atrial Tachycardia Clinical Trial
Official title:
A Prospective Multi-centre Study of Effectiveness of Ripple Mapping for Atrial Tachycardia Ablation
Tachycardia's (fast heart rhythms) can lead to troublesome palpitations, dizziness, blackouts
and breathlessness. They are caused either by a cluster of abnormal cells within the heart,
or an electrical short circuit which rotates rapidly around the heart. Sometimes these can be
controlled with tablets, though owing to side effects many patients want something else. Many
tachycardia's can be cured by a procedure known as an "ablation". In essence, either the
focus of abnormal cells or the narrowest point of the short circuit causing the abnormal
heart rhythm (the source) is electrically destroyed (burnt) resulting in restoration of the
normal heart beat.
One form of tachycardia is known is Atrial Tachycardia (AT). These arise from the top two
chambers of the heart (the atrium). Interestingly, this problem is frequently seen in
patients who have previously undergone an ablation or surgical procedure for a condition
called Atrial Fibrillation. In others the reason for its occurrence is unknown. Current
strategies to find the "source" during an ablation procedure are technically challenging
resulting in long procedure times. Sometimes the wrong source is found resulting in ablation
at the incorrect site.
Ripple Mapping (RM) is a novel system that Investigators at Imperial College are looking to
study. RM displays electrical information within the heart as a series of bars coming out of
the chamber, with each bar representing signals travelling down the heart. By seeing the
pattern of electrical information, they believe it will show the pattern of the tachycardia
better than conventional techniques. In a previous retrospective study that they conducted,
RM found the source of the tachycardia in 80% of the maps, compared to only 50% with the
current system. Investigators at Imperial College have identified why they did not get 100%
and they believe that, in future, RM will find the source of the tachycardia first time, and
every time.
Conventional mapping strategies used to find the "source" of "atrial tachycardia" within the
heart are technically challenging resulting in long procedure times. Sometimes the wrong
source is found resulting in ablation at the incorrect site.
In a retrospective study conducted by investigators at Imperial College, Ripple Mapping (RM)
found the source of the tachycardia 80% of the time, compared to only 50% with conventional
maps (known as local activation time maps). They have since studied the reasons why did not
achieve 100%, but could not improve matters with a retrospective data-set. They believe that,
in future, Ripple mapping will find the source of the tachycardia first time, and every time.
The purpose of this study is to prospectively test whether Ripple Mapping is better at
finding the source of the "atrial tachycardia" (AT) than conventional local activation time
mapping.
Patients referred for clinically indicated AT ablation by their electro-physiologist will be
recruited. For each patient recruited to the study, they will be block randomized into 2
arms: Ripple Mapping guided AT ablation, or Conventional AT guided Ablation (local activation
time mapping). Following explanation of the study the patients will be allowed time to decide
on whether they would like to participate.
Following completion of the consent procedure the patient will undergo the electrophysiology
study as is routine standard practice. This is usually performed by inserting plastic tubes
(catheters) into the heart using the vessels in the groin. Once the catheter is in the atrium
(top chambers of the heart) the catheter will be moved to different locations in the chamber
to gather the electrical information of the tissue. Using "CARTO3v4 ConfiDENSE", a
3-Dimensional map of the geometry of the heart chambers will be constructed.
Patient randomized to RM will proceed as follows: Once sufficient points have been collected,
the Ripple Map will be played in order to diagnose the source of the tachycardia. In the
context of a clear diagnosis, the operator can proceed to ablation at the defined source from
the Ripple map. Termination of the tachycardia with ablation will be used to confirm the
diagnosis was correct. A single entrainment is permissible where the diagnosis is unclear.
Patients randomized to conventional local activation time (LAT) mapping will proceed
according to standard practice of the operator. When the operator is satisfied adequate
number of points have been collected, the operator can proceed to ablation if the diagnosis
is clear. A single entrainment is permissible where the diagnosis is unclear. The endpoints
measured will include:
1. Tachycardia change or termination following first series of ablations with Ripple
Mapping vs local activation time mapping.
2. The reliance on entrainment.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00247351 -
Prevention of Atrial Tachycardia After a Right Atriotomy
|
N/A | |
Completed |
NCT04162249 -
High Radiofrequency Power for Faster and Safer Pulmonary Veins Isolation - a Pilot Observational Study.
|
||
Recruiting |
NCT03209583 -
ATrial Tachycardia PAcing Therapy in Congenital Heart
|
||
Recruiting |
NCT03750435 -
Non-fluoroscopy Ablation of AF/AT
|
N/A | |
Recruiting |
NCT05883631 -
RESOLVE-AF: Clinical Evaluation of the Ablacathâ„¢ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
|
N/A | |
Recruiting |
NCT05434650 -
Abbott Atrial Fibrillation Post Approval Study
|
||
Completed |
NCT06335446 -
Identification, Electro-mechanical Characterisation and Ablation of Driver Regions in Persistent Atrial Fibrillation
|
||
Recruiting |
NCT05014802 -
Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
|
||
Completed |
NCT05362656 -
AutoMatic disPERsion Tagging Function Preliminary Evaluation
|
N/A | |
Completed |
NCT05344456 -
PVC Response ''Atrial Pace'' Inducing Atrial Tachycardias
|
N/A | |
Not yet recruiting |
NCT05765565 -
Comparison Between the Octaray and Pentaray Catheters in Patients Undergoing Ablation for Atrial Tachycardia.
|
N/A | |
Recruiting |
NCT05521451 -
Clinical Cohort Study - TRUST
|
||
Not yet recruiting |
NCT06327425 -
MCG for Localization of Tachyarrhythmia's Origin
|
N/A | |
Completed |
NCT03549806 -
Stanford Cardiac Invasive Electrophysiology Novel Computer Experience
|
||
Recruiting |
NCT03816033 -
Cryotherapy Versus Radiofrequency Catheter Ablation Research Program
|
N/A | |
Completed |
NCT05802576 -
Study of Interference Between Oral Anticoagulants and Heparin During Ablation of Atrial Fibrillation (AF) or Left Atrial Tachycardia (GAD) by Catheter.
|
||
Completed |
NCT01108692 -
Strategy of Early Detection and Active Management of Supraventricular Arrhythmia With Telecardiology (SETAM)
|
N/A | |
Active, not recruiting |
NCT02374359 -
Atrial Tachycardia as a Predictor of Atrial Fibrillation, Stroke and Mortality in Cryptogenic Stroke
|
N/A | |
Completed |
NCT03151278 -
Zero Fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for Right Atrial Arrhythmias
|
N/A | |
Completed |
NCT03413150 -
Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias
|